ArticleArquivos de neuro-psiquiatria2024

A needle in a haystack? The impact of a targeted epilepsy gene panel in the identification of a treatable but rapidly progressive metabolic epilepsy: CLN2 disease.

Charles Marques Lourenço et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.